204 Participants Needed

Smartphone-Based Dietary Support for Obesity

SP
Overseen ByStephanie P Goldstein, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: The Miriam Hospital
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial does not specify whether you need to stop taking your current medications, but you cannot participate if you are currently taking weight loss medication.

What data supports the effectiveness of the treatment Smartphone-Based Dietary Support for Obesity?

Research shows that mobile eHealth interventions, which include smartphone-based approaches, can effectively promote weight loss and maintenance by encouraging behavior changes. Additionally, tailored informational interventions and self-management education have been successful in helping individuals lose weight and improve dietary habits.12345

Is smartphone-based dietary support for obesity safe for humans?

The research on mobile and web-based interventions for obesity, which includes smartphone-based dietary support, generally shows positive effects on weight management and dietary habits. While the studies focus on effectiveness, they do not report any significant safety concerns, suggesting these interventions are generally safe for human use.35678

How is the Smartphone-Based Dietary Support for Obesity treatment different from other obesity treatments?

This treatment is unique because it uses a smartphone app to provide personalized dietary support, combining education, motivation, and self-monitoring to help people manage their weight. It emphasizes self-regulation and tailored advice, which has been shown to be more effective than non-tailored interventions in supporting weight loss.568910

What is the purpose of this trial?

This project targets dietary lapses (instances of nonadherence to dietary goals), a major cause of poor outcomes during behavioral obesity treatment, which is a recommended first-line intervention for cardiovascular disease. The investigators propose to conduct a micro-randomized trial (MRT) to empirically optimize a smartphone-based just-in-time adaptive intervention (JITAI) that monitors risk and intervenes on lapses as needed. By evaluating the immediate, proximal effect of four theory-driven interventions on lapse behavior, the project will: (a) produce a scalable, finalized JITAI that has the greatest potential to show clear clinical impact in future trials; and (b) inform the development of more sophisticated theoretical models of adherence behavior more broadly. Therefore, this study has three goals. First the investigators aim to compare the effects of delivering any intervention to no intervention on the occurrence of lapse. Second, the investigators aim to compare the effects of specific theory-driven interventions to one another to determine which ones are best for preventing lapses. Within this second aim, the investigators also aim to examine other factors that may influence the effectiveness of interventions (e.g., time, location). Lastly, the investigators will use the data from this MRT to customize intervention delivery in future versions of this JITAIPatients will be recruited through various methods including advertisements in local media, targeted online advertising, advertisements in medical and minority communities, and direct mailers. All participants will receive a well-established 3-month online obesity treatment program, with 3 months of no-treatment follow-up. In conjunction, they will use a smartphone-based JITAI consisting of: 1) repeated daily surveys assess lapses and relevant triggers; 2) a machine learning algorithm that uses information from the surveys to determine real-time lapse risk; \& 3) interventions to counter lapse risk. When an individual is at risk for lapsing she will be randomly assigned to no intervention, a generic risk alert, or one of 4 theory-driven interventions with interactive skills training. The outcome of interest will be the occurrence (or lack thereof) of dietary lapse, as measured both subjectively (i.e., reported by the participant in the daily surveys) and objectively (i.e., via wrist-based intake monitoring), in the hours following randomization initiated by heightened lapse risk.

Eligibility Criteria

This trial is for adults aged 18-70 with a BMI of 25-50 and at least one cardiovascular risk factor like prediabetes, type 2 diabetes, high cholesterol, or hypertension. They must be able to walk two blocks without stopping and not be in another weight loss program or have conditions that affect study participation.

Inclusion Criteria

Your body mass index (BMI) falls between 25 and 50 kg/m².
I have been diagnosed with a condition that increases my risk for heart disease.
I can walk 2 city blocks without needing to stop.

Exclusion Criteria

Plans to become pregnant within 6 months of enrolling
Has any condition that would result in inability to follow the study protocol, including terminal illness, substance abuse, eating disorder (not including Binge Eating Disorder) and untreated major psychiatric illness.
I have had weight loss surgery in the past.
See 6 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person or virtual)

Baseline Assessment

Participants complete baseline questionnaires and self-reported logs of dietary intake and ecological momentary assessments (EMA) for 1 week before the baseline assessment.

1 week
1 visit (in-person or virtual)

Treatment

Participants receive 3 months of online behavioral obesity treatment (BOT) and use the JITAI system to monitor and intervene on dietary lapses.

3 months
Daily interaction with JITAI, 1 assessment visit at 3 months

Follow-up

Participants continue using the JITAI system without the behavioral obesity treatment for an additional 3 months.

3 months
1 assessment visit at 6 months

Treatment Details

Interventions

  • Enhanced Education
  • Generic Risk Alert (Active Comparator)
  • Motivation
  • Online Behavioral Obesity Treatment
  • Self-Efficacy
  • Self-Regulation
Trial Overview The trial tests a smartphone-based intervention to prevent dietary lapses during obesity treatment. It uses daily surveys, machine learning for lapse risk assessment, and various interventions when there's a high risk of lapsing. The effectiveness of these interventions will be compared.
Participant Groups
6Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Self-regulationExperimental Treatment2 Interventions
Theory-driven intervention focused on providing skills to increase self-regulation
Group II: Self-efficacyExperimental Treatment2 Interventions
Theory-driven intervention focused on providing skills to increase self-efficacy for following dietary goals
Group III: MotivationExperimental Treatment2 Interventions
Theory-driven intervention focused on providing skills to increase motivation for following dietary goals
Group IV: Enhanced EducationExperimental Treatment2 Interventions
Theory-driven intervention focused on providing information about dietary quality and goals
Group V: Generic Risk AlertActive Control2 Interventions
A notification to alert participant of lapse risk, no additional intervention provided
Group VI: No InterventionPlacebo Group1 Intervention
No notification or intervention is delivered to the participant during lapse risk

Find a Clinic Near You

Who Is Running the Clinical Trial?

The Miriam Hospital

Lead Sponsor

Trials
252
Recruited
39,200+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Findings from Research

Recent advancements in internet and cell phone interventions have shown that technology-enabled self-management education can significantly improve outcomes for patients with diabetes, including better self-management, medication adherence, and weight loss.
Research indicates that these interventions are effective across various age groups, from teens to older adults, suggesting a broad applicability that could lead to increased recognition and reimbursement from payors for these valuable treatments.
Information technology in the service of diabetes prevention and treatment.Kaufman, N.[2022]
In a study of 60 obese patients over 24 months, those who received a therapy program focused on nutritional education and intensive follow-up showed a significant decrease in body mass index (%BMI), especially in females after 18 months.
The program had a higher success rate in females (40.5%) compared to males (5.5%), indicating that gender may influence the effectiveness of obesity management strategies.
[Influence of nutritional education on management of infantile-juvenile obesity].Durá Travé, T.[2013]
Mobile eHealth behavioral interventions have the potential to effectively promote and sustain weight loss and maintenance, especially when they are well-designed and tailored to individual needs.
The review highlights that tailored informational interventions have been the most successful conventional methods for weight loss, and the advancements in mobile technology present new opportunities to enhance these interventions for broader public health impact.
Mobile eHealth interventions for obesity: a timely opportunity to leverage convergence trends.Tufano, JT., Karras, BT.[2018]

References

Information technology in the service of diabetes prevention and treatment. [2022]
[Influence of nutritional education on management of infantile-juvenile obesity]. [2013]
Mobile eHealth interventions for obesity: a timely opportunity to leverage convergence trends. [2018]
Examining motivational interviewing plus nutrition psychoeducation for weight loss in primary care. [2019]
Behavioral Nutrition Interventions Using e- and m-Health Communication Technologies: A Narrative Review. [2019]
Computer-assisted dieting: effects of a randomized nutrition intervention. [2019]
The use of web-based interventions to prevent excessive weight gain. [2012]
A pilot randomized trial of simplified versus standard calorie dietary self-monitoring in a mobile weight loss intervention. [2023]
Does self-monitoring diet and physical activity behaviors using digital technology support adults with obesity or overweight to lose weight? A systematic literature review with meta-analysis. [2021]
Detailed Versus Simplified Dietary Self-monitoring in a Digital Weight Loss Intervention Among Racial and Ethnic Minority Adults: Fully Remote, Randomized Pilot Study. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security